Clinical Trials Logo

Filter by:
NCT ID: NCT01554462 Completed - Healthy Clinical Trials

The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD

Start date: January 2009
Phase: N/A
Study type: Interventional

Forty children with and 40 children without Attention deficit Hyperactivity Disorder (ADHD) receive Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) or placebo via a dietary intervention. Cognitive control functions are measured with functional Magnetic Resonance Imaging (MRI) before and after the intervention. Behavioural change is monitored with behavioural scales.

NCT ID: NCT01553968 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects

Start date: April 2012
Phase: N/A
Study type: Interventional

It has been suggested that imbalance between TCA-cycle flux and β-oxidation may underlie insulin resistance, a predisposing factor for the development of type 2 diabetes mellitus. Acetylcarnitine concentration is suggested to be a marker of such imbalance. It is expected that when TCA-cycle capacity is high (a high oxidative capacity), less acetylcarnitine will accumulate, because of an improved balance between supply and demand of lipids. The major research objective is to examine if acute exercise results in a more pronounced increase in acetylcarnitine concentration in sedentary subjects compared to endurance-trained subjects and if the exercise-induced increase in acetylcarnitine is restored more quickly in endurance-trained subjects when compared to sedentary subjects. The investigators hypothesize that the increase in acetylcarnitine levels will be lower in trained subjects when compared to sedentary subjects, due to a better balance between lipid supply and utilization by the TCA-cycle. Furthermore it is expected that acetylcarnitine concentrations will be restored faster in these trained subjects, because of a tighter regulation of influx of fatty acids. To test this hypothesis the investigators want to compare the acetylcarnitine response to exercise in a group of sedentary subjects and a group of endurance trained subjects. This response will be measured for 30 minutes after exercise with the use of 1H-MRS.

NCT ID: NCT01552941 Completed - Clinical trials for Rheumatoid Arthritis

Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid Arthritis

Start date: July 2011
Phase: N/A
Study type: Interventional

This is a 12 week open label pilot study to determine the efficacy and safety of a surgically implanted, electrically active vagal nerve stimulation device in patients with active rheumatoid arthritis.

NCT ID: NCT01551511 Completed - Chronic Pain Clinical Trials

Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

Start date: October 2012
Phase: Phase 2
Study type: Interventional

Abdominal pain resulting from chronic pancreatitis (CP) is often recurrent, intense and long-lasting, and is extremely difficult to treat. Medical analgesic therapy is considered as first choice in pain management of CP, resulting in regularly prescription of opioids. The adverse consequences of prolonged opioid use, including addiction, tolerance and opioid induced hyperalgesia, call for an alternative medical treatment. Cannabis has been used to treat pain for many centuries. Delta-9-tetrahydrocannabinol (Δ9-THC), the psychoactive substance of the cannabis plant, has been shown in previous studies to be a promising analgesic. The development of Namisol®, a tablet containing purified Δ9-THC showing an improved pharmacokinetic profile, provides the opportunity to test the analgesic potential of Δ9-THC in favourable conditions. The current study aims to investigate the analgesic efficacy of Namisol® as add-on analgesic during a long-term treatment (52 days) of abdominal pain resulting from CP.

NCT ID: NCT01551225 Completed - Clinical trials for Irritable Bowel Syndrome

Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder

Start date: January 2012
Phase: Phase 4
Study type: Interventional

This study will be executed according to a randomized double-blind placebo-controlled trial with two parallel groups, treated over the period of 6 months with escitalopram or placebo. Hypotheses: Escitalopram is more effective than placebo in the control of gastrointestinal symptoms, in irritable bowel syndrome (IBS) patients with panic disorder. Escitalopram is more effective than placebo in the control of psychiatric symptoms, in IBS patients with panic disorder.

NCT ID: NCT01549535 Completed - Colon Cancer Clinical Trials

Polyp Detection With The Peerscope System™

Start date: February 2012
Phase: Phase 2
Study type: Interventional

The PeerScope System consists of Peer Medical camera heads, endoscopes, video system, light source and other ancillary equipment. The system is intended for endoscopic diagnosis, treatment and video observation of the digestive tract. The PeerScope system model B is indicated for use for endoscopy and endoscopic treatment within the lower digestive tract (including the anus, rectum, sigmoid colon, colon and ileocecal valve) of adults patients. Objective:To compare the additional diagnostic yield obtained by using the PeerScope System™ extended view vs. the diagnostic yield obtained by the Standard view colonoscopy. In addition, time measurements including time to cecum, time for withdrawal and overall procedure time will be analyzed and reported for each group.

NCT ID: NCT01549483 Completed - Asthma Clinical Trials

Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR)

ABHR
Start date: May 2012
Phase: N/A
Study type: Observational

The purpose of this study is to study differences in small airways (<2mm) parameters in asthma patients, subjects with asymptomatic airway hyperresponsiveness and healthy controls.

NCT ID: NCT01549106 Completed - Healthy Volunteers Clinical Trials

IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study

Start date: August 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IPI-145 after single and repeat oral administration, and to evaluate the effects of food and ketoconazole on the plasma pharmacokinetics of IPI-145.

NCT ID: NCT01548703 Completed - Healthy Clinical Trials

A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers

Start date: February 2012
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BCI-838 and its metabolite BCI-632 in healthy male and female subjects.

NCT ID: NCT01546922 Completed - Clinical trials for Adrenal Insufficiency

Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)

SUPREME CORT
Start date: February 2012
Phase: Phase 4
Study type: Interventional

The aim of this study is to investigate whether a physiologically low hydrocortisone (HC) dose is better for cognition as compared to a physiologically high HC dose. In addition, quality of life, metabolic profile and somatosensation will be described in relation to HC dose.